For centuries, river blindness (onchocerciasis) plagued remote communities in Africa. The Programme was set up in 1995 to expand and build on the successes of the Onchocerciasis Control Programme in West Africa (OCP). The goal of the African Programme for Onchocerciasis Control (APOC) is to eliminate onchocerciasis as a disease of public health importance in Africa.
At the heart of APOC’s strategy to eliminate onchocerciasis is community-directed treatment with ivermectin (CDTI). This approach relies on active community participation to distribute ivermectin treatment. Communities plan their own distribution systems and make decisions about how and when the ivermectin is distributed. They decide which members of the community will be trained to deliver the treatment, and they also monitor the CDTI process.
At the end of 2012, more than 100.8 million (76.4%) people living in 24 African APOC country members received ivermectin treatment, of the 131 939 719 at-risk population to onchocerciasis in poor rural communities.
|Location||West Africa, Ghana, Togo, Tanzania, Southern Sudan, Sierra Leone, Senegal, Nigeria, Mali, Malawi, Liberia, Guinea-Bissau, Guinea, Ethiopia, Equatorial Guinea, Congo, The Democratic Republic of, Chad, Central African Republic, Cameroon, Burundi, Burkina Faso, Benin, Angola, Southern Africa, Eastern Africa, Central Africa, Uganda|
|Value||USD 236 Million|